Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Restless Leg Syndrome”

Showing 17 of 0 results

Large-scale testing (Phase 3)Study completedNCT00136045
What this trial is testing

Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

Who this might be right for
Restless Legs Syndrome
UCB Pharma 549
Large-scale testing (Phase 3)Study completedNCT00498108
What this trial is testing

Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects

Who this might be right for
Idiopathic Restless Legs Syndrome
UCB Pharma 341
Large-scale testing (Phase 3)Ended earlyNCT03728933
What this trial is testing

Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

Who this might be right for
Restless Legs Syndrome
UCB Biopharma SRL 23
Testing effectiveness (Phase 2)Study completedNCT01562743
What this trial is testing

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

Who this might be right for
Idiopathic Restless Legs Syndrome
Otsuka Pharmaceutical Co., Ltd. 185
Large-scale testing (Phase 3)Study completedNCT00654498
What this trial is testing

Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 306
Large-scale testing (Phase 3)Study completedNCT00275457
What this trial is testing

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 346
Large-scale testing (Phase 3)Study completedNCT00152958
What this trial is testing

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 224
Not applicableStudy completedNCT01386944
What this trial is testing

Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

Who this might be right for
Restless Legs Syndrome
UCB Pharma 102
Not applicableStudy completedNCT01113710
What this trial is testing

Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise

Who this might be right for
Idiopathic Restless Legs Syndrome
UCB Pharma 687
Large-scale testing (Phase 3)Study completedNCT00357097
What this trial is testing

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome

Who this might be right for
Restless Legs SyndromeModerate to Severe Idiopathic Restless Legs Syndrome (RLS)
GlaxoSmithKline 240
Testing effectiveness (Phase 2)Study completedNCT00243217
What this trial is testing

Rotigotine Restless Legs Syndrome Dose Finding Trial

Who this might be right for
Idiopathic Restless Leg Syndrome
UCB Pharma 341
Large-scale testing (Phase 3)Study completedNCT01084551
What this trial is testing

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Who this might be right for
Idiopathic Restless Legs Syndrome
Otsuka Pharmaceutical Co., Ltd. 284
Testing effectiveness (Phase 2)Study completedNCT01495793
What this trial is testing

Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome

Who this might be right for
Restless Legs Syndrome
UCB BIOSCIENCES, Inc. 42
Large-scale testing (Phase 3)Study completedNCT00806026
What this trial is testing

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

Who this might be right for
Idiopathic Restless Legs Syndrome
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 731
Large-scale testing (Phase 3)Study completedNCT00133198
What this trial is testing

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 345
Post-approval studies (Phase 4)Study completedNCT00472199
What this trial is testing

Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Boehringer Ingelheim 331
Large-scale testing (Phase 3)Study completedNCT01569464
What this trial is testing

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
UCB Pharma 150

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation